Introduction
Many genetic alterations in both oncogenes and tumor suppressor genes contribute to multistep carcinogenesis in humans (Sugimura, 1992) . The fact that several oncogene products, including Bcr-Abl and v-Src, possess high protein tyrosine kinase activity suggests that carcinogenesis is promoted by the aberrant phosphorylation of cellular targets of these enzymes (Cantley et al., 1991; Fantl et al., 1993) . Protein tyrosine phosphatases (PTPs) likely also affect carcinogenesis, given that they counteract the action of protein tyrosine kinases (Tonks, 1993; Walton and Dixon, 1993; Hunter, 1995) . Indeed, certain PTPs have been associated with the development of some types of cancer. For example, the expression of HPTPb is decreased in many lung cancers (De Vries et al., 1991) , and the gene encoding PTPg is frequently deleted in both renal and lung cancers (LaForgia et al., 1991; Tsukamoto et al., 1992) .
Human hepatocellular carcinoma (HCC) has been thought to develop as a consequence of combinations of abnormalities in various genes such as those encoding Rb, p53, p16, and telomerase (Rogler and Chisari, 1992; Nishida et al., 1993; Tahara et al., 1995) . As in other cell types, the tyrosine phosphorylation of cellular proteins is indispensable for the growth and differentiation of hepatocytes (Palmer et al., 1999) . In addition, the expression of several PTPs is upregulated during regeneration of the liver after partial hepatectomy in mice and rats (Higashitsuji et al., 1995; Kitamura et al., 1995; Saito et al., 1996) . These observations thus implicate tyrosine phosphorylation events and, hence, PTPs in hepatocellular function under both physiological and pathological conditions. Dysfunction of PTPs may thus contribute to the development of HCC, although few studies to date have implicated specific PTPs in the pathogenesis of this disease (Ikuta et al., 1994; Kitamura et al., 1995) .
SAP-1 (stomach cancer-associated protein tyrosine phosphatase-1) was first identified as a transmembranetype (receptor-like) PTP that is abundant in a subset of pancreatic and colorectal cancer cell lines (Matozaki et al., 1994) . This enzyme belongs to the class 2 subfamily of receptor-like PTPs and is structurally similar to HPTPb, DEP-1, and DPTP10D (Krueger et al., 1990; Tian et al., 1991; Ostman et al., 1994) . We have recently shown that SAP-1 mediates the dephosphorylation of several focal adhesion-associated substrates and, consequently, inhibits cell proliferation by suppressing growth factor-elicited mitogenic signaling as well as by inducing apoptotic cell death (Noguchi et al., 2001; Takada et al., 2002) . The enzymatic activity of SAP-1 is also increased in cells that exhibit densitydependent growth arrest (Noguchi et al., 2001) . Furthermore, the abundance of SAP-1 mRNA increases during differentiation of breast cancer cells in response to anticancer drugs (Keane et al., 1996) . These observations suggest that SAP-1 might act as a tumor suppressor by generating a signal that results in growth arrest and differentiation of cancer cells. However, the potential roles of this PTP in carcinogenesis have remained unclear.
SAP-1 is abundant in the liver (Matozaki et al., 1994) and might therefore contribute to the initiation or progression of HCC. To investigate this hypothesis, we have now examined the expression of SAP-1 in human HCCs at various stages of differentiation. Our results show that the abundance of SAP-1 is inversely related to the aggressiveness of HCC. Furthermore, we show that forced expression of SAP-1 in highly motile HCC cells resulted in a morphological change that was accompanied by a marked reduction in cell migration.
Results

Expression of SAP-1 in human HCCs
HCC specimens from 32 individuals were examined for SAP-1 expression by immunohistochemical analysis with two different antibodies specific for this protein.
The clinical characteristics of the patients are provided in Table 1 , and representative immunohistochemical data are shown in Figure 1 . In normal hepatocytes, SAP-1 was detected predominantly at the cell membrane and to a lesser extent in the cytoplasm (Figure 1a , e). Immunoreactivity was not apparent in sinusoidal endothelial cells, whereas epithelial cells of the bile duct yielded a moderate signal (Figure 1a , e). The endothelium of the portal tract vessels was weakly positive for SAP-1, but mesenchymal cells were negative (Figure 1a , e). Nine of 12 (75%) well-differentiated (WD) HCCs expressed SAP-1 at a level similar to or higher than that apparent in the surrounding noncancerous tissue, although the remaining three WD-HCCs also expressed a substantial amount of this protein (Figure 1b, f and Table 2 ). In 12 of 14 (85.7%) specimens of moderately differentiated (MD) HCC, the abundance of SAP-1 in the cancerous tissue was substantially lower than that in the adjacent noncancerous tissue (Figure 1c , g and Table 2 ). All six poorly differentiated (PD) HCCs contained much smaller amounts of SAP-1 than did the surrounding noncancerous tissue (Figure 1d , h and Table 2 ); indeed, SAP-1 was almost undetectable in five of six (83.3%) PD-HCCs (Table 2) . Thus, the level of expression of SAP-1 in human HCC appeared positively related to the differentiation status of the tumor.
Immunoblot analysis revealed that the abundance of SAP-1 in liver tissue affected by chronic hepatitis or cirrhosis was similar to that in normal liver tissue (Figure 2a) . Consistent with the immunohistochemical data, the amount of SAP-1 in WD-HCC tissue was greater than that in MD-HCC or PD-HCC (Figure 2b ). In contrast, the expression of SAP-1 in the surrounding cirrhotic tissue of these different tumors appeared similar (Figure 2b ).
The relation between the level of SAP-1 expression and the differentiation status of HCC was then analysed statistically. Among the three stages of HCC differentiation, the abundance of SAP-1 decreased in the rank order WD-HCC4MD-HCC4PD-HCC (Po0.01 for WD-HCC versus MD-HCC and for MD-HCC versus PD-HCC) (Figure 3) . Furthermore, the amount of SAP-1 in either MD-HCC or PD-HCC tissue was significantly smaller than that in the respective noncancerous tissue, with this reduction being more pronounced for PD-HCC (Figure 3 ). The abundance of SAP-1 in adjacent noncancerous tissue did not differ significantly among individuals with WD-HCC, with MD-HCC, or with PD-HCC. Given that human HCC progresses through dedifferentiation of the tumor, these results indicate that the level of SAP-1 expression is inversely related to tumor aggressiveness.
Effects of ectopic expression of SAP-1 on HCC cell morphology and migration
A reduced abundance of SAP-1 might contribute to the acquired characteristics of advanced HCC such as the abilities to metastasize and to invade tissue. Alternatively, it might be a consequence of disease progression. To distinguish between these possibilities, we transfected HLF and HLE cells, both of which are highly motile and were derived from human PD-HCC (Doi et al., 1975) , with an expression vector encoding SAP-1. Endogenous SAP-1 was virtually undetectable in both of these cell lines (Figure 4 ). Several independent transfectants that stably expressed exogenous SAP-1 were generated from each cell line (Figure 4 ). Two clones established from HLF cells (F-SAP-A and F-SAP-C) and one clone from HLE cells (E-SAP-d) Tyrosine phosphatase SAP-1 in human hepatocellular carcinoma H Nagano et al were studied most extensively, although the other clones showed similar phenotypes (data not shown). Under normal culture conditions, parental cells of each cell line, as well as cells transfected with the empty vector, exhibited an elongated, spindle-like morphology, appeared to be loosely associated, and freely migrated out of colonies (Figure 5a, b) . In contrast, both F-SAP-C ( Figure 5a ) and E-SAP-d (Figure 5b ) cells exhibited a flattened, less polarized morphology and formed compact colonies in which cells were tightly connected with each other. Fluorescence analysis with rhodaminelabeled phalloidin revealed that parental HLF cells and cells transfected with the empty vector possess substantial number of both actin stress fibers that cross the cell body and filopodia-like microspikes at the cell periphery ( Figure 5c ). In marked contrast, F-SAP-C cells exhibited few actin stress fibers, with disorganized actin filaments apparent in the subcortical region and cytoplasm ( Figure 5c ). Thus, forced expression of SAP-1 The immunohistochemical signal intensity for SAP-1 expression was classified as either 1 (faint), 2 (weak), 3 (moderate), or 4 (strong) 
Tyrosine phosphatase SAP-1 in human hepatocellular carcinoma H Nagano et al in HCC cells induced morphological changes and disruption of actin-based cytoskeleton. We previously observed similar changes induced by SAP-1 overexpression in Chinese hamster ovary cells (Noguchi et al., 2001) . We also examined the migratory capacity of the established HCC cell lines with the use of a Boyden chamber assay, in which cells move through a porous membrane coated with collagen type I. A substantial number of both parental HLF cells and cells transfected with the empty vector migrated in this assay (Figure 6 ). However, the number of cells that migrated through the membrane was markedly reduced for two independent cell lines (F-SAP-A and F-SAP-C) expressing exogenous SAP-1 (Figure 6 ).
Effect of ectopic expression of SAP-1 on HCC cell growth
To further address the potential role of SAP-1 in the pathogenesis of HCC, we monitored the growth rate of the established cell lines. As shown in Figure 7 , the growth rate of HLF cells expressing SAP-1 was substantially lower than that of control cells.
Discussion
We have shown that the dedifferentiation of human HCC is accompanied by a decrease in the level of expression of SAP-1; the protein was thus most abundant in WD-HCC, which is characterized by low rates of growth and metastasis (Kim et al., 1995) . Furthermore, expression of recombinant SAP-1 in Effect of overexpression of SAP-1 on the migration of HCC cells. The indicated lines derived from HLF cells were seeded onto porous membranes that had been coated with collagen type I and placed in Boyden multiwell chambers. After incubation for 48 h at 371C, the number of cells that had migrated through the membrane was determined as described in the Materials and methods section. Data are expressed as absorbance at 570 nm and are means7s.d. of triplicate determinations from three independent experiments. N.S., not significant; *Po0.01 highly motile HCC cells resulted in a change in morphology that was accompanied by a marked reduction in migratory activity and growth rate. These results, together with our previous observations that SAP-1 suppresses mitogenic and survival signaling (Noguchi et al., 2001; Takada et al., 2002) , suggest that this PTP negatively regulates the progression of human HCC.
Most PD-HCCs contained almost undetectable amounts of SAP-1, indicating that the expression of this protein is downregulated at the later stages, but not at the early stage, of human HCC. This observation appears inconsistent with our previous data showing that SAP-1 is abundant in colorectal cancer tissue but not in the corresponding normal tissue (Matozaki et al., 1994) . However, we also showed previously that the abundance of SAP-1 decreases with the progression of colorectal tumors (Seo et al., 1997) , as was the case with HCC in the present study. Furthermore, for a few individuals with WD-HCC, the level of expression of SAP-1 was greater in the cancerous tissue than in the adjacent noncancerous tissue. As far as we are aware, the expression of PTPs in human HCC has not previously been examined in relation to differentiation status, although extracellular signal-regulated kinases (Ito et al., 1998) and the proto-oncogene c-MYC (Kawate et al., 1999) have been shown to be upregulated in PD-HCC. Our results thus identify SAP-1 as a PTP whose expression is induced at the early stage of human HCC and suppressed at later stages. Interestingly, the pattern of expression of RPTPa, a receptor-like PTP structurally similar to SAP-1, during the development of human breast cancer (Ardini et al., 2000) is similar to that of SAP-1 during HCC progression.
Tissue invasion and metastasis are characteristic features of advanced HCC and are critically regulated by cell motility (Genda et al., 1999) . If the observed downregulation of SAP-1 expression was simply a consequence of dedifferentiation of HCC, forced expression of the recombinant protein would not be expected to have a substantial effect on the behavior of cells derived from PD-HCC. Indeed, we have shown that expression of SAP-1 in highly motile HLF and HLE cells resulted in a change in morphology as well as a marked decrease in migratory activity. These results suggest that SAP-1 normally inhibits the motility of HCC cells and that this PTP plays a role in keeping the tumor cells well differentiated. Together with the observation that the abundance of SAP-1 decreases at the later stages of HCC, our results support the notion that downregulation of SAP-1 contributes, at least in part, to the enhanced abilities of advanced HCC to metastasize and invade tissue.
With regard to the mechanism by which SAP-1 inhibits the migration of HCC cells, we have previously shown that this PTP negatively regulates integrinmediated signaling by catalyzing the dephosphorylation of p130
Cas and focal adhesion kinase (Noguchi et al., 2001) , both of which play important roles in cell migration (Hanks and Polte, 1997; Schlaepfer et al., 1999) . Furthermore, increased expression and tyrosine phosphorylation of these proteins promote the migratory and invasive activities of various cancer cells, including HCC cells (Klemke et al., 1998; Tamura et al., 1999; Imamura et al., 2000) . SAP-1-mediated dephosphorylation of these focal adhesion-associated proteins, therefore, likely results in inhibition of the migration of HCC cells. Integrin-mediated signaling has been shown to induce disassembly of intercellular adherens junctions mediated by E-cadherin, a key step of cancer invasion and metastasis (Genda et al., 2000; Ojakian et al., 2001) . It is thus possible that expression of SAP-1 prevents HCC metastasis not only by inhibiting cell motility but also by stabilizing cell-cell adhesion in the primary cancer nest.
In conclusion, our results demonstrate that the level of SAP-1 expression correlates with the differentiation status of human HCC. Furthermore, overexpression of this PTP both affected the morphology of HCC cells as well as markedly reduced their migratory activity and growth rate. Together, our results suggest that the downregulation of SAP-1 may play a causal role in the progression of this fatal disease.
Materials and methods
Patients and tissue samples
HCC specimens including adjacent noncancerous tissue were obtained with written informed consent from 32 individuals admitted to Kobe University Hospital; 27 of the specimens Table 1 . A total of 30 of the study subjects exhibited underlying cirrhosis and the remaining two had chronic hepatitis. The etiologic factors included hepatitis B virus (eight patients), hepatitis C virus (23 patients), and alcohol (one patient). The differentiation status of each tumor was classified into three categories as described by Edmondson and Steiner (1954) . Two normal liver tissue specimens were obtained by surgical excision from individuals with liver metastasis of colon cancer. All specimens were split into two portions, one of which was immediately frozen in liquid nitrogen and stored at À801C until protein extraction, and the other was fixed in 10% formalin and embedded in a paraffin block. The university ethics committee approved this study.
Immunohistochemistry
Immunohistochemical staining was performed with the use of a large volume DAKO LSAB Kit (DAKO, Copenhagen, Denmark). In brief, fixed sections were depleted of paraffin by three treatments (each for 5 min) with xylene, dehydrated in ethanol, and incubated with 3% hydrogen peroxide for 15 min in order to quench endogenous peroxidase activity. After digestion with 0.1% trypsin for 5 min at room temperature, the sections were incubated first with a blocking solution for 30 min and then overnight at 41C with either rabbit polyclonal antibodies (1 : 50 dilution) (Seo et al., 1997) or mouse monoclonal antibody 3G5 (1 : 200 dilution) (Noguchi et al., 2001) to SAP-1 diluted in phosphate-buffered saline (PBS). The sections were washed with 50 mm Tris-HCl (pH 7.6) and then incubated for 1 h at room temperature first with biotinylated secondary antibodies to rabbit or mouse immunoglobulin G (DAKO) and then with horseradish peroxidaseconjugated streptavidin (Amersham Pharmacia Biotech, Little Chalfornt, UK). The sections were then counterstained with hematoxylin, mounted on cover slides, and examined with a light microscope (OPTIPHOT, Nikon, Tokyo). The signal intensity was classified into one of the four levels by two independent pathologists who were not aware of the specimen identity.
Immunoblot analysis
Liver tissue or cultured cells were homogenized on ice in RIPA buffer (20 mm Tris-HCl (pH 7.4), 150 mm NaCl, 2 mm EDTA, 1% sodium deoxycholate, 0.1% SDS, 1% Nonidet P-40) containing 5 mm NaF, 1 mm phenylmethylsulfonyl fluoride, aprotinin (10 mg/ml), and leupeptin (1 mg/ml). The homogenate was clarified by centrifugation at 10 000 g for 15 min at 41C, after which the protein concentration of the supernatant was normalized. Samples containing either 400 mg of tissue protein or 100 mg of cellular protein were suspended in Laemmli sample buffer, boiled, and then fractionated by SDSpolyacrylamide gel electrophoresis on a 7.5% gel. Immunoblot analysis with polyclonal antibodies to SAP-1 or to actin (Sigma) was performed with the use of the ECL detection system (Amersham Pharmacia Biotech) as described previously (Kameda et al., 1990; Morita et al., 1997) .
Cells and transfection
HLF and HLE cells were obtained from the Japanese Cancer Research Resources Bank (Tokyo, Japan) and were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, penicillin (100 U/ml), and streptomycin (100 mg/ml) (GIBCO BRL, Grand Island, NY, USA). Cells (70% confluent in 60-mm dishes) were transfected with 1 mg either of pSRa containing human SAP-1 cDNA (Matozaki et al., 1994) or of the empty vector with the use of an Effectene Transfection Kit (QIAGEN, Hilden, Germany). The cells were cultured for 48 h in normal growth medium and then exposed to G418 (600 mg/ml) (GIBCO BRL). The resulting G418-resistant colonies were isolated 3 weeks after transfection, and stable transfectants were identified by immunoblot analysis with polyclonal antibodies to SAP-1 as described above.
Assay of cell morphology
Cells were seeded at a density of 1 Â 10 5 cells/ml on 60-mm dishes and cultured in a humidified incubator containing 5% CO 2 . Exponentially growing cells were examined under a light microscope equipped with phase-contrast optics (TM-PSF, Nikon) and random fields were photographed. For staining of filamentous actin, cells seeded on glass coverslips were washed with PBS, fixed with 3.7% formaldehyde in PBS for 20 min, permeabilized with 0.5% Triton X-100 in PBS for 5 min, and incubated for 2 h in TBS-T (20 mm Tris-HCl (pH 7.6), 150 mm NaCl, 0.05% Tween-20) containing 5% nonfat dry milk, 10% fetal bovine serum, and 1% bovine serum albumin. The cells were then incubated for 1 h at room temperature with rhodamine-labeled phalloidin (0.1 mg/ml) (Sigma). After three washes with PBS, the cells were examined with a laser-scanning confocal microscope (Bio-Rad model MRC-1024), and builtup images were constructed.
Assay of cell migration
Cell migration was assessed with the use of a QCM-Collagen I Quantitative Cell Migration Assay Kit (Chemicon, Temecula, CA, USA). In brief, cells deprived of serum for 24 h were detached from culture dishes by treatment with Hanks' balanced salt solution containing 0.53 mm EDTA and 0.05% trypsin. The cells (2.5 Â 10 5 in 0.5 ml of serum-free medium containing 5% bovine serum albumin) were added to each of the collagen type I-coated membranes (pore size, 8 mm) that had been placed at the bottom of the upper wells. After incubation for 48 h at 371C in a humidified incubator containing 5% CO 2 , cells that had migrated through the membrane were exposed to a staining solution for 30 min at room temperature. The stain was then eluted from the cells with 300 ml of an extraction buffer, the absorbance of which at 570 nm was then measured with a microtiter plate reader.
Assay of cell growth
Cells were seeded in 96-well culture plates at a density of 1 Â 10 3 per well and cultured in the presence of 10% fetal bovine serum at 371C in a humidified incubator containing 5% CO 2 . The culture medium was changed every 3 days, and the rate of cell growth was determined every 24 h with the use of a Cell Proliferation Assay Kit (Chemicon, Temecula, CA, USA).
Statistical analysis
Data are expressed as means7s.d. Continuous variables were evaluated by the Mann-Whitney U test, and discrete variables were assessed by the Kruskal-Wallis test. A P-value of o0.05 was considered statistically significant.
